Interestingly, our study found that knocking down ETV4 leads to an upregulation of FGL1 expression in RBE and SK-hep1 cells, while the opposite effect was observed in pancreatic cancer cells and tumors, where ETV4 knockdown resulted in the downregulation of FGL1 expression. Here, ETV4 is linked to pancreatic neoplasm.